Sign in

CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870419387
Phone
310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Open-market buy Chairman and CEO bought 4,500 shares at an average $0.88 ($3,970)
  2. D/A Other Amended Notice of Exempt Offering of Securities
  3. 4 Open-market buy Chairman and CEO bought 1,500 shares at an average $1.02 ($1,530)
  4. 8-K/A Event Unregistered share sale
  5. D/A Other Amended Notice of Exempt Offering of Securities
  6. 4 Open-market buy Chairman and CEO bought 3,250 shares at an average $0.94 ($3,040)
  7. D Other Notice of Sales of Unregistered Securities
  8. 4 Open-market buy Chairman and CEO bought 9,750 shares at an average $0.99 ($9,685)
  9. 4 Open-market buy Chairman and CEO bought 3,500 shares at an average $1.02 ($3,555)
  10. 8-K/A Event Exhibits
  11. 8-K Event Material agreement · New debt or obligation
  12. 4 Open-market buy Chairman and CEO bought 500 shares at $1.20 ($600)
  13. 4 Open-market buy Chairman and CEO bought 300 shares at $1.30 ($390)
  14. 8-K Event Auditor change
  15. 4 Open-market buy Chairman and CEO bought 1,000 shares at $1.20 ($1,200)
  16. 4 Open-market buy Chairman and CEO bought 1,500 shares at $1.19 ($1,785)
  17. 4 Open-market buy Chairman and CEO bought 1,000 shares at $1.25 ($1,250)
  18. 4 Open-market buy Chairman and CEO bought 1,950 shares at an average $1.37 ($2,665)
  19. 8-K Event Executive or director change
  20. 4 Open-market buy Chairman and CEO bought 750 shares at an average $1.60 ($1,198)

Page 12 of 63 · 1,250 filings